Thalys(SH:603716) Shang Hai Zheng Quan Bao·2025-09-12 20:03Core Viewpoint - The announcement details the pledge of shares by the controlling shareholder of Saily Medical Technology Group Co., Ltd., indicating a significant portion of shares has been pledged, but the company maintains that this will not affect its operations or control [2][5][6]. Group 1: Share Pledge Details - The controlling shareholder, Saihai (Shanghai) Health Technology Co., Ltd., holds 21,642,540 shares, representing 10.30% of the total share capital, and has pledged 3,000,000 shares recently [2]. - After the recent pledge, Saihai Technology has a total of 17,000,000 pledged shares, which is 78.55% of its holdings and 8.09% of the total share capital [2]. - The actual controller, Mr. Wen Wei, holds 9,634,208 shares (4.58% of total share capital) and has pledged 5,300,000 shares, which is 55.01% of his holdings [2]. Group 2: Future Pledge and Financing - Within the next six months, 6,000,000 shares are set to mature, accounting for 19.18% of their holdings and 2.86% of total share capital, with a corresponding financing balance of 14.61 million yuan [5]. - In the next year, an additional 9,000,000 shares will mature, representing 28.78% of their holdings and 4.28% of total share capital, with a financing balance of 36 million yuan [5]. - The funds from the recent pledge are primarily intended to repay previous pledge financing debts, and the company asserts that it has the ability to repay these debts [5][6]. Group 3: Risk Management and Impact - The company states that the pledge will not impact its operations, main business, financing costs, or ongoing viability, and there is no risk of a change in actual control [6]. - The credit status of Saihai Technology and Mr. Wen Wei is reported to be good, with manageable pledge risks, and they are prepared to take measures if stock prices approach warning or liquidation levels [6].